Bioaugmentation of electrogenic halophiles in the treatment of pharmaceutical industrial wastewater and energy production in microbial fuel cell under saline condition.

Pharmaceutical wastewater with different toxic recalcitrant materials and high salinity requires a novel treatment technology before released into the environment. The present research details the treatment of pharmaceutical wastewater along with energy production using bioaugmentation of halophilic consortium in air cathode microbial fuel cell (ACMFC) under saline condition (4%). Organic load (OL) varied from 1.04 to 3.51 gCOD/L was studied in ACMFC. TCOD (Total Chemical Oxygen Demand) removal exhibited 65%, 72%, 84% and 89% at 1.04, 1.52, 2.01 and 2.52 gCOD/L OL respectively. SCOD (Soluble Chemical Oxygen Demand) removal of 60%, 66%, 76% and 82% was recorded during the operation of identical OL (1.04-2.52 gCOD/L). Prominent TCOD (92%), SCOD (90%), TSS (Total Suspended Solids) removal of 73% was attained at 3.02 gCOD/L OL with corresponding energy production of 896 mV (Current density (CD) - 554 mA/m, Power density (PD)-505 mW/m). CE (Columbic Efficiency) was 43%, 38%, 33%, 30%, 28% and 22% at different OL ranged between 1.04 and 3.51 gCOD/L. Increase in OL to 3.51 gCOD/L revealed decrement in TCOD (68%), SCOD (62%), TSS (52%) removal and energy production (CD-234 mA/m, PD-165 mW/m). Complete removal of phenol was accomplished at different OL in 6 (1.04, 1.52 gCOD/L) and 8 (2.01, 2.52 and 3.02 gCOD/L) days respectively. Ochrobactrum, Marinobacter, Bacillus and Rhodococcus were the dominant halophilic electrogenic strain in ACMFC at different OL.